J 2020

Prediction Score for persisting perfusion defects after pulmonary embolism

MRÓZEK, Jan, Tereza NEČASOVÁ, Michal SVOBODA, Iveta ŠIMKOVÁ, Pavel JANSA et. al.

Základní údaje

Originální název

Prediction Score for persisting perfusion defects after pulmonary embolism

Autoři

MRÓZEK, Jan (203 Česká republika), Tereza NEČASOVÁ (203 Česká republika, domácí), Michal SVOBODA (203 Česká republika, domácí), Iveta ŠIMKOVÁ (203 Česká republika) a Pavel JANSA (203 Česká republika)

Vydání

Biomedical Papers, Olomouc, Univerzita Palackého v Olomouci, 2020, 1213-8118

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 1.245

Kód RIV

RIV/00216224:14110/20:00115108

Organizační jednotka

Lékařská fakulta

UT WoS

000604951200007

Klíčová slova anglicky

pulmonary embolism; prediction score; perfusion defects; reperfusion; risk score; classification

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 1. 2021 10:26, Mgr. Tereza Miškechová

Anotace

V originále

Long-term persistence of perfusion defect after pulmonary embolism (PE) may lead to the development of chronic thromboembolic pulmonary hypertension. Identification of patients at risk of such a complication using a scoring system would be beneficial in clinical practice. Here, we aimed to derive a score for predicting persistence of perfusion defects after PE.Methods. 83 patients after PE were re-examined 6, 12 and 24 months after the PE episode. Data collected at the time of PE and perfusion status during follow-ups were used for modelling perfusion defects persistence using the Cox proportional hazards model and validated using bootstrap method.Results. A simple scoring system utilizing two variables (hemoglobin levels and age at the time of PE) was developed. Patients with hemoglobin levels over 140 g/L who were older than 65 years were at the highest risk of perfusion defects; in patients with the same hemoglobin levels and age {\&}lt; 65 years, the risk was reduced by 79{\%}, and by 89{\%} in patients with hemoglobin {\&}lt; 140 g/L.Conclusion. The proposed scoring system may be useful in clinical practice for identifying patients with high risk of persisting perfusion defects, flagging them for closer follow up, thus improving the effectiveness of long-term treatment of patients after PE.